oxandrolone has been researched along with Hyperlipoproteinemia Type III in 1 studies
Oxandrolone: A synthetic hormone with anabolic and androgenic properties.
Hyperlipoproteinemia Type III: An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a CHOLESTEROL to TRIGLYCERIDES ratio greater than that of VERY-LOW-DENSITY LIPOPROTEINS. This disorder is due to mutation of APOLIPOPROTEINS E, a receptor-binding component of VLDL and CHYLOMICRONS, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxandrolone was administered to two hypertriglyceridemic subjects, one with type III and one with type V hyperlipoproteinemia until plasma triglycerides were below the target level of 270 mg/dl." | 1.26 | Oxandrolone and plasma triglyceride reduction: effect on triglyceride-rich and high density lipoproteins. ( Gotto, AM; Hara, T; Miller, JP; Patsch, JR, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, T | 1 |
| Miller, JP | 1 |
| Gotto, AM | 1 |
| Patsch, JR | 1 |
1 other study available for oxandrolone and Hyperlipoproteinemia Type III
| Article | Year |
|---|---|
Oxandrolone and plasma triglyceride reduction: effect on triglyceride-rich and high density lipoproteins.
Topics: Adult; Blood Proteins; Cholesterol; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type | 1981 |